Consequences of daily corticosteroid dosing with or without pre-treatment with quinidine on the in vivo cytochrome P450 2D (CYP2D) enzyme in rats: effect on O-demethylation activity of dextromethorphan and expression levels of CYP2D1 mRNA

References

• Bochner F, Somogyi AA, Chen ZR. (1994). Dextromethorphan metabolism in rat: interstrain differences and the fate of individually administered oxidative metabolites. Xenobiotica 24:543–52
   PubMed Web of Science ®Google Scholar
• Brasen K, Gram LF. (1989). Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 36:537–47
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Mintzer S, Pack AM, et al. (2013). Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia 54:11–27
   PubMed Web of Science ®Google Scholar
• Chen XP, Tan ZR, Huang SL, et al. (2003). Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects. Clin Pharmacol Ther 73:264–71
   PubMed Web of Science ®Google Scholar
• Choi YH, Lee MG. (2006). Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. Br J Pharmacol 149:424–30
   PubMed Web of Science ®Google Scholar
• Corchero J, Granvil CP, Akiyama TE, et al. (2001). The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse. Mol Pharmacol 60:1260–7
   PubMed Web of Science ®Google Scholar
• Deng Y, Wang L, Yang Y, et al. (2013). In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6. Drug Metab Pharmacokinet 28:339–44
   PubMed Web of Science ®Google Scholar
• Farooq M, Kelly EJ, Unadkat JD. (2016). CYP2D6 is inducible by endogenous and exogenous corticosteroids. Drug Metab Dispos 44:750–7
   PubMed Web of Science ®Google Scholar
• Ferguson CS, Tyndale RF. (2011). Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 32:708–14
   PubMed Web of Science ®Google Scholar
• Fery Y, Mueller SO, Schrenk D. (2010). Development of stably transfected human and rat hepatoma cell lines for the species-specific assessment of xenobiotic response enhancer module (XREM)-dependent induction of drug metabolism. Toxicology 277:11–19
   PubMed Web of Science ®Google Scholar
• Feuer G, Kardish R. (1975). Hormonal regulation of drug metabolism during pregnancy. Int J Clin Pharmacol Biopharm 11:366–74
   PubMedGoogle Scholar
• Hakkola J, Tanaka E, Pelkonen O. (1998). Developmental expression of Cytochrome P450 enzymes in human liver. Pharmacol Toxicol 82:209–17
   PubMedGoogle Scholar
• Hellum BH, Hu Z, Nilsen OG. (2007). The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol 100:23–30
   PubMed Web of Science ®Google Scholar
• Hiroi T, Chow T, Imaoka S, et al. (2002). Catalytic specificity of CYP2D isoforms in rat and human. Drug Metab Dispos 30:970–6
   PubMed Web of Science ®Google Scholar
• Hiroi T, Imaoka S, Funae Y. (1998). Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun 249:838–43
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. (2004). Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5:6–13
   Web of Science ®Google Scholar
• Iwanaga K, Honjo T, Miyazaki M, et al. (2013). Time-dependent changes in hepatic and intestinal induction of cytochrome P450 3A after administration of dexamethasone to rats. Xenobiotica 43:765–73
   PubMed Web of Science ®Google Scholar
• Kellermann G, Luyten-Kellermann M. (1977). Phenobarbital-induced drug metabolism in man. Toxicol Appl Pharmacol 39:97–104
   PubMed Web of Science ®Google Scholar
• Kerry NL, Somogyi AA, Mikus G, et al. (1993). Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes. Biochem Pharmacol 45:833–9
   PubMed Web of Science ®Google Scholar
• Kim YC, Shim HJ, Lee JH, et al. (2005). Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats. Biopharm Drug Dispos 26:233–41
   PubMed Web of Science ®Google Scholar
• Koh KH, Pan X, Shen HW, et al. (2014). Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice. J Biol Chem 289:3105–13
   PubMed Web of Science ®Google Scholar
• Kishi R, Sata F, Katakura Y, et al. (2005). Effects of pregnancy, age and sex in the metabolism of styrene in rat liver in relation to the regulation of cytochrome P450 enzymes. J Occup Health 47:49–55
   PubMed Web of Science ®Google Scholar
• Leslie JD, Suzanne T, Tauri DS, et al. (2008). Changes in maternal liver cyp2c and cyp2d expression and activity during rat pregnancy. Biochem Pharmacol 75:1677–87
   PubMed Web of Science ®Google Scholar
• Geng P, Cai J, Wang S, et al. (2015). Effect of diphenoxylate on CYP450 isoforms activity in rats. Int J Clin Exp Med 8:18800–6
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (1997). Role of cytochrome P450 enzymes in drug-drug interactions. Adv Pharmacol 43:7–35
   PubMedGoogle Scholar
• Maki O, Kiyoto M, Teruo O, et al. (2009). Induction of drug-metabolizing enzymes by phenobarbital in layered co-culture of a human liver cell line and endothelial cells. Biol Pharm Bull 32:813–17
   PubMed Web of Science ®Google Scholar
• Marier JF, Pope LE, Yakatan GJ, et al. (2004). Influence of concomitant quinidine administration on dextromethorphan disposition in rats. J Vet Pharmacol Therap 27:111–14
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Donovan JL, DeVane CL, et al. (2003). Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. Jama 290:1500–4
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GM, de Kanter R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875–94
   PubMed Web of Science ®Google Scholar
• McMillan DM, Tyndale RF. (2015). Nicotine increases codeine analgesia through the induction of brain cyp2d and central activation of codeine to morphine. Neuropsychopharmacology 40:1804–12
   PubMed Web of Science ®Google Scholar
• Meyer UA, Skoda RC, Zanger UM. (1990). The genetic polymorphism of debrisoquine/sparteine metabolism—molecular mechanisms. Pharmac Ther 46:297–308
   PubMed Web of Science ®Google Scholar
• Miksys S, Rao Y, Hoffmann E, et al. (2002). Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem 82:1376–87
   PubMed Web of Science ®Google Scholar
• Miksys S, Tyndale RF. (2004). The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev 36:313–33
   PubMed Web of Science ®Google Scholar
• Morganroth J, Horowitz LN. (1985). Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmias. Am J Cardiol 56:585–7
   PubMed Web of Science ®Google Scholar
• Nakajima T, et al. (1992). Sex-, age- and pregnancy-induced changes in the metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. J Pharmacol Exp Ther 261:869–74
   PubMed Web of Science ®Google Scholar
• Noriko E, Kei-Ichi K, Kunio D. (2005). Induction of cytochrome P450 isozymes by phenobarbital in pregnant rat and fetal livers and placenta. Exp Mol Pathol 78:150–5
   PubMed Web of Science ®Google Scholar
• Oertel B, Lotsch J. (2008). Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics 9:179–94
   PubMed Web of Science ®Google Scholar
• Pan X, Koh K, Yu AM, et al. (2013). Induction of CYP2D6 expression during pregnancy is associated with an increased activity of hepatocyte nuclear factor 4α. FASEB Journal 27:1102.3
   Web of Science ®Google Scholar
• Pelkonen O, Turpeinen M, Hakkola J, et al. (2008). Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82:667–715
   PubMed Web of Science ®Google Scholar
• Ringel M, Oesch F, Gerl M, et al. (2002). Permissive and suppressive effects of dexamethasone on enzyme induction in hepatocyte co-cultures. Xenobiotica 32:653–66
   PubMed Web of Science ®Google Scholar
• Ryu RJ, Eyal S, Easterling TR, et al. (2016). Pharmacokinetics of metoprolol during pregnancy and lactation J Clin Pharmacol. 56:581–9
   PubMed Web of Science ®Google Scholar
• Stephen DW, Clark C, Hans GS, et al. (2002). Quinidine does not affect the renal clearance of moxonidine. Br J Clin Pharmacol 54:251–4
   PubMed Web of Science ®Google Scholar
• Sugiyama E, Kikuchi A, Inada M, Sato H. (2011). The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats. J Pharm Sci 100:3995–4005
   PubMed Web of Science ®Google Scholar
• Tabei T, Heinrichs WL. (1976). Hepatic steroid hydroxylase and aminopyrine N-demethylase activities in pregnant rats and rabbits, and the effect of phenobarbital. Biochem Pharmacol 25:2099–101
   PubMed Web of Science ®Google Scholar
• Tushar T, Vinod T, Rajan S, et al. (2007). Effect of honey on CYP3A4, CYP2D6 and CYP2C19 enzyme activity in healthy human volunteers. Basic Clin Pharmacol Toxicol 100:269–72
   PubMed Web of Science ®Google Scholar
• Tracy TS, Venkataramanan R, Glover DD, et al. (2005). National Institute for child health and human development network of maternal-fetal-medicine units – temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 192:633–9
   PubMed Web of Science ®Google Scholar
• Uchida S, Tanaka S, Namiki N. (2014). Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats. Biopharm Drug Dispos 35:228–36
   PubMed Web of Science ®Google Scholar
• Wadelius M, Darj E, Frenne G, et al. (1997). Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther 62:400–7
   PubMed Web of Science ®Google Scholar
• Wilkinson GR. (2005). Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–21
   PubMed Web of Science ®Google Scholar
• Wooding SRA, Visco J, S J, Slaughter RL. (1988). The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine. Br J Clin Pharmacol 26:415–21
   PubMed Web of Science ®Google Scholar
• Yu AM, Idle JR, Gonzalez FJ. (2004). Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates. Drug Metab Rev 36:243–77
   PubMed Web of Science ®Google Scholar
• Yue J, Miksys S, Hoffmann E, et al. (2008). Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course. J Psychiatry Neurosci 33:54–63
   PubMed Web of Science ®Google Scholar